Neglected Tropical Disease Drug Discovery Booster
This multi-company collaborative project with the Drugs for Neglected Diseases Initiative (DNDi) is focused on...
Global Biopharmaceutical Industry Commitment
to Address Coronavirus Public Health Crisis
As part of the global health community, biopharmaceutical companies are committed to playing the greatest possible role in the rapid, global response to COVID-19. Learn about our commitments and how we're leading the way in developing diagnostics, treatments and vaccines for COVID-19.
